pSANG10-3F Citations (3)

Originally described in: A simple vector system to improve performance and utilisation of recombinant antibodies.
Martin CD, Rojas G, Mitchell JN, Vincent KJ, Wu J, McCafferty J, Schofield DJ BMC Biotechnol. 2006 Dec 7;6:46. PubMed Journal

---

Articles Citing pSANG10-3F

Articles
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. Radhakrishnan SV, Luetkens T, Scherer SD, Davis P, Vander Mause ER, Olson ML, Yousef S, Panse J, Abdiche Y, Li KD, Miles RR, Matsui W, Welm AL, Atanackovic D. Nat Commun. 2020 Feb 7;11(1):798. doi: 10.1038/s41467-020-14619-z. PubMed
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Vander Mause ER, Baker JM, Dietze KA, Radhakrishnan SV, Iraguha T, Omili D, Davis P, Chidester SL, Modzelewska K, Panse J, Marvin JE, Olson ML, Steinbach M, Ng DP, Lim CS, Atanackovic D, Luetkens T. Sci Transl Med. 2023 Jul 19;15(705):eadd7900. doi: 10.1126/scitranslmed.add7900. Epub 2023 Jul 19. PubMed
Selection, alkaline phosphatase fusion, and application of single-chain variable fragment (scFv) specific to NT-proBNP as electrochemical immunosensor for heart failure. Wongjard S, Aiemderm P, Monkhang K, Jaengwang K, Tabtimmai L, Kraiya C, Choowongkomon K, Swainson NM. Heliyon. 2023 Sep 1;9(9):e19710. doi: 10.1016/j.heliyon.2023.e19710. eCollection 2023 Sep. PubMed

If you have published an article using this material, please email us at to have your article added to this page.